Cargando…
Prospective Validation of the ROL System in Substaging pT1 High-Grade Urothelial Carcinoma: Results from a Mono-Institutional Confirmatory Analysis in BCG Treated Patients
SIMPLE SUMMARY: The management of patients with non-muscle-invasive, high-grade urothelial carcinoma represents a challenging issue for urologists. The ROL system is a method to evaluate tumor invasion and substage pT1 urothelial carcinoma. In this study, we aimed to confirm in a large and prospecti...
Autores principales: | Valeri, Marina, Contieri, Roberto, Fasulo, Vittorio, Iuzzolino, Martina, Cieri, Miriam, Elefante, Grazia M., De Carlo, Camilla, Bressan, Alessandra, Saitta, Cesare, Gobbo, Andrea, Avolio, Pier Paolo, Dacrema, Valerio, Lazzeri, Massimo, Taverna, Gianluigi, Terracciano, Luigi M., Hurle, Rodolfo, Colombo, Piergiuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913603/ https://www.ncbi.nlm.nih.gov/pubmed/36765894 http://dx.doi.org/10.3390/cancers15030934 |
Ejemplares similares
-
Clinical and pathological predictors of persistent T1 HG at second resection
por: Gobbo, Andrea, et al.
Publicado: (2023) -
Usefulness of pT1 substaging in papillary urothelial bladder carcinoma
por: Patriarca, Carlo, et al.
Publicado: (2016) -
Intravesical gemcitabine as bladder‐preserving treatment for BCG unresponsive non‐muscle‐invasive bladder cancer. Results from a single‐arm, open‐label study
por: Hurle, Rodolfo, et al.
Publicado: (2020) -
Intratumoral Switch of Molecular Phenotype and Overall Survival in Muscle Invasive Bladder Cancer
por: De Carlo, Camilla, et al.
Publicado: (2022) -
Long-term Follow-up After En Bloc Transurethral Resection of Non–muscle-invasive Bladder Cancer: Results from a Single-center Experience
por: Paciotti, Marco, et al.
Publicado: (2021)